NWPF

Search Results Tagged With Parkinsons Medical Therapy

Spinal Cord Stimulation Protects Against Parkinson's Symptoms

https://nwpf.org/stay-informed/news/2014/01/spinal-cord-stimulation-protects-against-parkinsons-symptoms/

In a study conducted on rodents, researchers at Duke Medicine discovered that spinal cord stimulation helps in temporarily easing the symptoms of Parkinson's disease, a progressive neurological disord…
January 30, 2014

Tiny cellular bubbles enable delivery of Parkinson's drugs straight to the brain

https://nwpf.org/stay-informed/news/2015/05/tiny-cellular-bubbles-enable-delivery-of-parkinson’s-drugs-straight-to-the-brain/

Cellular bubbles (exosomes) that are extracted from human immune cells could deliver catalase (an enzyme that proves to be an effective treatment) to pass through brain’s defense and therefore to opti…
May 05, 2015

How do I best time doses of carbidopa/Ldopa?

https://nwpf.org/stay-informed/blog/2013/03/how-do-i-best-time-doses-of-carbidopaldopa/

The following excerpt is from a question received by NWPF. We were told by our neurologist that my husband should take carbidopa/Ldopa (Sinemet) every 5 hours and also told to take it with meals. Wha…
March 17, 2013

Manage nausea from medicines

https://nwpf.org/stay-informed/blog/2012/03/manage-nausea-from-medicines/

I get nausea in the morning. Could this be caused by my medicines? All dopaminergic medicines can cause nausea. Nausea is worse when you first start a medicine and can increase as you increase dose.…
March 16, 2012

AbbVie Announces U.S. FDA Approval of DUOPA™ Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease

https://nwpf.org/stay-informed/news/2015/03/abbvie-announces-us-fda-approval-of-duopa™/

DUOPA is a new approach to the administration of carbidopa and levodopa for the treatment of motor fluctuations for people with advanced Parkinson's disease.
March 19, 2015

Deep Brain Stimulation May Ease Some Parkinson's Pain for Years

https://nwpf.org/stay-informed/news/2015/03/deep-brain-stimulation-may-ease-some-parkinsons-pain-for-years/

People with Parkinson's disease who undergo deep brain stimulation may experience long-term pain relief, a small, new study from Korea suggests. However, three-quarters of the patients developed new p…
March 23, 2015

Hopes of vaccine for Parkinson’s sufferers

https://nwpf.org/stay-informed/news/2015/04/hopes-of-vaccine-for-parkinson’s-sufferers/

Toxins such as "prions" which could be one of the causes of Parkinson's development could be obstructed by vaccine.
April 25, 2015

FDA lifts clinical hold on NeuroDerm's ND0612 to treat Parkinson's disease

https://nwpf.org/stay-informed/news/2015/05/fda-lifts-clinical-hold-on-neuroderms-nd0612-to-treat-parkinsons-disease/

The US Food and Drug Administration (FDA) has lifted the clinical hold on Israeli pharmaceutical firm NeuroDerm's US clinical studies of its primary product candidates, ND0612H and ND0612L, which are …
May 11, 2015

Low-dose lithium reduces side effects from most common treatment for Parkinson's disease

https://nwpf.org/stay-informed/news/2015/07/low-dose-lithium-reduces-side-effects-from-most-common-treatment-for-parkinsons-disease/

Low-dose lithium reduced involuntary motor movements - the troubling side effect of the medication most commonly used to treat Parkinson's disease (PD) - in a mouse model of the condition that is diag…
July 27, 2015

Parkinson's disease may be treatable with antimalaria drugs

https://nwpf.org/stay-informed/news/2015/07/parkinsons-disease-may-be-treatable-with-antimalaria-drugs/

There are currently no standard treatments that slow or stop Parkinson's disease - available therapies address each patient's individual symptoms. Now, a breakthrough study successfully identifies two…
July 17, 2015

<< Back 11 - 20 of 22 Next >>